The Board of Directors of Genomictree Inc. Ltd has authorized a buyback plan on May 17, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
20,150 KRW | -1.71% | -3.36% | -2.18% |
2023 | Genomictree Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
2022 | Tranche Update on Genomictree Inc.'s Equity Buyback Plan announced on May 17, 2022. | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-2.18% | 357M | |
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+24.73% | 12.17B | |
+28.31% | 12.16B | |
-6.26% | 11.42B |
- Stock Market
- Equities
- A228760 Stock
- News Genomictree Inc.
- Genomictree Inc. Ltd authorizes a Buyback Plan.